Ascendis Pharma A/S - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ASND Nasdaq 2836 ascendispharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ascendis Pharma A/S

Liberty All-Star® Growth Fund, Inc. October 2025 Monthly Update - Nov 14th, 2025 3:08 pm
A Look at Ascendis Pharma (NasdaqGS:ASND) Valuation Following Q3 Growth and Pipeline Progress - Nov 14th, 2025 2:17 pm
How the Narrative for Ascendis Pharma Is Evolving Amid New Analyst Optimism and Challenges - Nov 14th, 2025 1:11 pm
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading - Nov 14th, 2025 9:02 am
Ascendis (ASND) Q3 2025 Earnings Call Transcript - Nov 13th, 2025 10:00 am
Ascendis Pharma AS (ASND) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Nov 12th, 2025 10:00 pm
Ascendis Pharma Reports Third Quarter 2025 Financial Results - Nov 12th, 2025 2:01 pm
The Bull Case For Ascendis Pharma (ASND) Could Change Following New Long-Term Renal Data on TransCon PTH - Nov 8th, 2025 8:15 pm
New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism - Nov 7th, 2025 6:30 am
Ascendis Pharma to Report Third Quarter 2025 Financial Results and Provide Business Update on November 12, 2025 - Nov 5th, 2025 2:01 pm
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Nov 5th, 2025 8:56 am
3-Year Renal Data in Adults with Hypoparathyroidism Treated with TransCon® PTH (Palopegteriparatide) to Be Shared at Kidney Week 2025 - Nov 3rd, 2025 2:01 pm
European Equities Traded in the US as American Depositary Receipts Little Changed in Monday Trading - Nov 3rd, 2025 9:24 am
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - Oct 21st, 2025 9:06 am
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - Oct 20th, 2025 9:01 am
Ascendis Pharma (NasdaqGS:ASND): Evaluating Valuation After Sharply Higher Share Price This Quarter - Oct 16th, 2025 8:09 am
Liberty All-Star® Growth Fund, Inc. September 2025 Monthly Update - Oct 14th, 2025 10:48 am
Walt Disney Upgraded, Southwest Airlines Downgraded: Updated Rankings on Top Blue-Chip Stocks - Oct 13th, 2025 10:29 am
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading - Oct 9th, 2025 9:04 am
Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon® CNP for Treatment of Children with Achondroplasia - Oct 8th, 2025 2:01 pm